Key result
Type 1 diabetes linked to increased arterial wall inflammation and hematopoietic activity on PET/CT.
Case-Control (n=61)
Answers are grounded in this paper and cite their sources.
Reveals elevated arterial wall inflammation and immune activation in type 1 diabetes, indicating heightened vascular risk independent of blood sugar control.
AIMS: The article investigates whether chronic hyperglycaemia in Type 1 diabetes (T1D) is associated with a proinflammatory immune signature and with arterial wall inflammation, driving the development of atherosclerosis. METHODS AND RESULTS: Patients with T1D (n = 41), and healthy age-, sex-, and body mass index-matched controls (n = 20) were recruited. Arterial wall inflammation and haematopoietic activity were measured with 2'-deoxy-2'-(18F)-fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography. In addition, flow cytometry of circulating leucocytes was performed as well as targeted proteomics to measure circulating inflammatory markers. 18F-FDG uptake in the wall of the abdominal aorta, carotid arteries, and iliac arteries was higher in T1D compared with that in the healthy controls. Also, 18F-FDG uptake in the bone marrow and spleen was higher in patients with T1D. CCR2 and CD36 expressions on circulating monocytes were higher in patients with T1D, as well as several circulating inflammatory proteins. In addition, several circulating inflammatory markers (osteoprotegerin, transforming growth factor-alpha, CX3CL1, and colony-stimulating factor-1) displayed a positive correlation with FDG uptake. Within T1D, no differences were found between people with a high and low HbA1c. CONCLUSION: These findings strengthen the concept that chronic hyperglycaemia in T1D induces inflammatory changes that fuel arterial wall inflammation leading to atherosclerosis. The degree of hyperglycaemia appears to play a minor role in driving this inflammatory response in patients with T1D.
No takes yet. Share an insight, caveat, or question.
Janssen et al. (2023) conducted a case-control in Type 1 diabetes (n=61). Type 1 diabetes (chronic hyperglycaemia) vs. Healthy age-, sex-, and BMI-matched controls was evaluated on Arterial wall inflammation and haematopoietic activity measured by 18F-FDG PET/CT. Type 1 diabetes (n=41) was associated with higher arterial wall, bone marrow, and spleen 18F-FDG uptake and elevated circulating inflammatory markers compared with healthy controls (n=20).
Synapse has enriched 10 related papers. Consider them for comparative context: